The short version of Method validation fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2026-07-03. Anything still debated is marked as such rather than presented as settled.
Practical HPLC testing depends on careful sample preparation and instrument maintenance. Samples may require filtration, dilution, pH adjustment, or extraction to avoid column damage and matrix interference. Mobile phases are degassed and filtered, and columns are equilibrated before injection. Common problems include peak tailing, baseline drift, ghost peaks, carryover, and co-elution of analytes. Documentation of instrument logs, calibration records, and electronic audit trails supports data integrity and traceability. Ongoing training and routine maintenance help reduce variability between analysts and laboratories.
Quality control laboratories use HPLC to check identity, purity, concentration, and stability of raw materials and finished products. A validated method specifies the column, mobile phase, flow rate, detection wavelength, injection volume, and run time. Samples are prepared and compared against reference standards of known concentration. The resulting chromatogram provides quantitative data, such as assay values and impurity levels. This approach is common in pharmaceutical, food, environmental, and industrial testing where consistent measurements are required.
System suitability testing is performed before and during analytical runs to confirm that the instrument and method are working as expected. Typical checks include retention time, peak area precision, resolution between critical pairs, tailing factor, and theoretical plate count. Acceptance criteria are set in the method or pharmacopeial monograph. If a suitability check fails, the run may be rejected and the instrument or sample preparation may need investigation. This practice helps prevent release of data from a system that has drifted out of control.
Quality control samples are inserted at intervals to monitor accuracy and precision throughout a batch. Blank samples detect contamination, while spiked samples assess recovery from the sample matrix. Calibration standards establish the relationship between detector response and concentration, and control samples are prepared independently from them whenever possible. Laboratories also participate in proficiency testing and maintain audit trails, instrument logs, and reagent records. Ongoing review of control charts can reveal trends before they cause out-of-specification results.
Method validation demonstrates that an HPLC procedure is suitable for its intended purpose. Common validation parameters include accuracy, precision, specificity, linearity, range, limit of detection, limit of quantification, and robustness. Accuracy reflects agreement with a reference value, while precision describes repeatability under defined conditions. Specificity shows whether the method can measure the analyte in the presence of impurities or matrix components. Validation documents are reviewed before a method is used for routine testing or regulatory submissions.
| Parameter | Typical acceptance criterion | Notes |
|---|---|---|
| Resolution | ≥ 1.5 | Baseline separation of adjacent peaks |
| Tailing factor | ≤ 2.0 | Peak symmetry measure |
| Theoretical plates | > 2000 | Column efficiency indicator |
| Injection repeatability | ≤ 2% RSD | Relative standard deviation for replicate injections |
| Linearity | r² ≥ 0.995 | Calibration curve over the working range |
HPLC testing separates dissolved compounds by passing a liquid sample through a column packed with stationary phase. A pump delivers mobile phase at controlled flow, and the sample components interact differently with stationary and mobile phases. Compounds that spend more time in mobile phase elute earlier; those retained by stationary phase elute later. Detectors record elution as peaks, and peak area or height relates to amount. This mechanism underpins quantitative analysis of mixtures.
Most routine HPLC testing uses reversed-phase columns, where the stationary phase is nonpolar and the mobile phase is a polar mixture such as water with an organic solvent. Analytes partition between the two phases according to polarity, size, and charge. Gradients that change solvent composition over time can separate compounds with broad retention ranges. Isocratic conditions keep solvent composition constant and suit simpler mixtures. The choice of column chemistry, pH, and temperature affects selectivity and peak shape.
== Advantages == Intermediate moisture foods utilize hurdle technology by lowering water activity, reducing pH and using preservatives. Most bacteria do not grow under a water activity of 0.90 and IMF processing methods reduce water activity to 0.60-0.84. IMFs are often ready-to-eat and do not require refrigeration. This is especially important in countries with tropical climates and minimal storage and processing capacities. Nitrites and sulfites are added to food to prolong shelf life and delay flavor and color changes. Propylene glycol reduces water activity and acts as a plasticizing agent to give food its desired texture. Compared to canning, dehydration, and freezing, IMF food processing is less rigorous and results in less nutrient loss. This is because compared to other processing techniques, IMF processes are at lower temperatures, pressures, and there is no water leaching of nutrients. Additionally, IMF production is more energy efficient compared to conventional processes including canning and freezing since IMFs do not require refrigeration. The energy required for canning and freezing is costly, thus IMF are common in developing countries.
===== MeSH D08.811.277.450 – glycoside hydrolases ===== MeSH D08.811.277.450.066 – amylases MeSH D08.811.277.450.066.050 – alpha-amylase MeSH D08.811.277.450.066.100 – beta-amylase MeSH D08.811.277.450.114 – beta-fructofuranosidase MeSH D08.811.277.450.207 – chitinase MeSH D08.811.277.450.283 – dextranase MeSH D08.811.277.450.329 – disaccharidases MeSH D08.811.277.450.329.738 – sucrase MeSH D08.811.277.450.329.738.700 – sucrase-isomaltase complex MeSH D08.811.277.450.329.865 – trehalase MeSH D08.811.277.450.400 – alpha-L-fucosidase MeSH D08.811.277.450.410 – galactosidases MeSH D08.811.277.450.410.050 – alpha-galactosidase MeSH D08.811.277.450.410.100 – beta-galactosidase MeSH D08.811.277.450.410.100.500 – lactase MeSH D08.811.277.450.410.150 – ceramide trihexosidase MeSH D08.811.277.450.410.400 – galactosylceramidase MeSH D08.811.277.450.420 – glucosidases MeSH D08.811.277.450.420.050 – alpha-glucosidases MeSH D08.811.277.450.420.200 – cellulases MeSH D08.811.277.450.420.200.100 – beta-glucosidase MeSH D08.811.277.450.420.200.200 – cellulase MeSH D08.811.277.450.420.200.400 – cellulose 1,4-beta-cellobiosidase MeSH D08.811.277.450.420.200.450 – endo-1,3(4)-beta-glucanase MeSH D08.811.277.450.420.200.500 – glucan 1,3-beta-glucosidase MeSH D08.811.277.450.420.200.550 – glucan 1,4-beta-glucosidase MeSH D08.811.277.450.420.200.600 – glucan endo-1,3-beta-d-glucosidase MeSH D08.811.277.450.420.375 – glucan 1,4-alpha-glucosidase MeSH D08.811.277.450.420.450 – glycogen debranching enzyme system MeSH D08.811.277.450.420.475 – glycosylceramidase MeSH D08.811.277.450.420.475.400 – glucosylceramidase MeSH D08.811.277.450.426 – glucuronidase MeSH D08.811.277.450.483 – hexosaminidases MeSH D08.811.277.450.483.021 – acetylglucosaminidase MeSH D08.811.277.450.483.044 – alpha-N-acetylgalactosaminidase MeSH D08.811.277.450.483.112 – Beta-N-acetylgalactosaminidase MeSH D08.811.277.450.483.180 – Beta-N-acetylhexosaminidase MeSH D08.811.277.450.483.765 – Mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase MeSH D08.811.277.450.529 – hyaluronoglucosaminidase MeSH D08.811.277.450.560 – iduronidase MeSH D08.811.277.450.585 – isoamylase MeSH D08.811.277.450.625 – mannosidases MeSH D08.811.277.450.625.500 – alpha-mannosidase MeSH D08.811.277.450.625.750 – beta-mannosidase MeSH D08.811.277.450.642 – muramidase MeSH D08.811.277.450.692 – neuraminidase MeSH D08.811.277.450.737 – n-glycosyl hydrolases MeSH D08.811.277.450.737.099 – dna glycosylases MeSH D08.811.277.450.737.099.500 – DNA-formamidopyrimidine glycosylase MeSH D08.811.277.450.737.099.750 – thymine dna glycosylase MeSH D08.811.277.450.737.400 – nad+ nucleosidase MeSH D08.811.277.450.737.400.060 – adp-ribosyl cyclase MeSH D08.811.277.450.737.400.060.500 – antigens, cd38 MeSH D08.811.277.450.770 – oligo-1,6-glucosidase MeSH D08.811.277.450.770.800 – sucrase-isomaltase complex MeSH D08.811.277.450.800 – polygalacturonase MeSH D08.811.277.450.950 – xylosidases MeSH D08.811.277.450.950.249 – endo-1,4-beta xylanases MeSH D08.811.277.450.950.500 – xylan endo-1,3-beta-xylosidase
Thus these two experiments are used to build so called spin systems, that is build a list of resonances of the chemical shift of the peptide proton, the alpha protons and all the protons from each residue's sidechain. Which chemical shifts corresponds to which nuclei in the spin system is determined by the conventional correlation spectroscopy connectivities and the fact that different types of protons have characteristic chemical shifts. To connect the different spinsystems in a sequential order, the nuclear Overhauser effect spectroscopy experiment has to be used. Because this experiment transfers magnetization through space, it will show crosspeaks for all protons that are close in space regardless of whether they are in the same spin system or not. The neighbouring residues are inherently close in space, so the assignments can be made by the peaks in the NOESY with other spin systems. One important problem using homonuclear nuclear magnetic resonance is overlap between peaks. This occurs when different protons have the same or very similar chemical shifts. This problem becomes greater as the protein becomes larger, so homonuclear nuclear magnetic resonance is usually restricted to small proteins or peptides.
He progressed to the quarterfinals after winning over Jaume Munar of Spain, Tomáš Macháč of Czech Republic, and Alexei Popyrin of Australia, all in straight sets. He was defeated in the quarterfinals by eventual bronze medalist Lorenzo Musetti of Italy in straight sets. In the American hard court swing, Zverev reached the quarterfinals in Montréal, losing to Sebastian Korda in three sets. He went on to defend his semifinal points in Cincinnati, losing to Jannik Sinner in an attritive three-set match. At the US Open, he reached the quarterfinals without facing a seeded opponent, with wins over lucky loser Maximilian Marterer, wildcard Alexandre Müller, Tomás Martín Etcheverry and Brandon Nakashima — his 450th career win. With that milestone, he became the second player born in the 1990s, after Grigor Dimitrov, to reach 450 ATP wins. With the win, he qualified for his seventh appearance at the 2024 ATP Finals. Zverev lost in the quarterfinals to Taylor Fritz. At the Paris Masters, Zverev defeated Tallon Griekspoor, Arthur Fils, and Stefanos Tsitsipas to set up a semifinal clash with former champion Holger Rune. He won the match in straight sets to reach the final for the second time at this event. Zverev defeated home crowd favorite Ugo Humbert in the final to clinch his second Masters title of the season and the world No. 2 ranking. Zverev won all three of his group matches at the ATP Finals to reach the semifinals, where he lost to Taylor Fritz in a deciding set tie-break.
Sources: en.wikipedia.org
In early 1983, Carrey decided to move to Hollywood where he began regularly performing at The Comedy Store. Getting on The Tonight Show became his immediate career goal, and, by spring 1983, he appeared to have achieved it after getting booked for a stand-up set on the highly-rated late night show. However, a lukewarm club set at The Improv got him unbooked. Though struggling to replicate his success in Los Angeles, Carrey continued being a big hit in his hometown Toronto where he returned during late April 1983 to perform at the short-lived B.B. Magoon's theatrical venue on Bloor Street on three consecutive nights. While in town, CTV's flagship newsmagazine program W5 did a feature on Carrey that aired nationally in Canada. Back in L.A., within months, he landed the main role on The Duck Factory, a sitcom being developed for NBC, and, in late November 1983, still got to debut his impressionist act on The Tonight Show Starring Johnny Carson via a promotional appearance for the sitcom about to start airing nationally in the United States on the same network. In the meantime, he was cast for a supporting role in the Warner Bros. comedy production Finders Keepers, shot in the Canadian province of Alberta during late summer 1983. For his Tonight Show appearance that aired on American Thanksgiving, 21-year-old Carrey went through his most popular impressions—Elvis Presley, Leonid Brezhnev, Jack Nicholson, Bruce Dern, Clint Eastwood, Charles Bronson, Michael Landon, James Dean, E.T.
"Amino Acid and Peptide Absorption and Transport across the Intestine". In Tsuda, T.; Sasaki, Y.; Kawashima, R. (eds.). Physiological Aspects of Digestion and Metabolism in Ruminants: Proceedings of the Seventh International Symposium on Ruminant Physiology. San Diego: Academic Press. pp. 111–28. ISBN 978-0-323-13861-1.
=== Citric acid cycle === α-Ketoglutarate is a component of the citric acid cycle, a cyclical metabolic pathway located in the mitochondria. This cycle supplies the energy that cells need by sequentially metabolizing (indicated by →) citrate through seven intermediate metabolites and then converting the eighth intermediate metabolite, oxaloacetate, back to citrate:
Sources: en.wikipedia.org
Galanin-like peptide (GALP) is a neuropeptide present in humans and other mammals. It is a 60-amino acid polypeptide produced in the arcuate nucleus of the hypothalamus and the posterior pituitary gland. It is involved in the regulation of appetite and may also have other roles such as in inflammation, sex behavior, and stress. Findings additionally suggest that GALP could play a function in energy metabolism due to its ability to maintain continual activation of the sympathetic nervous system (SNS) via thermogenesis, which refers to the production of heat within living organisms. In addition, the administration of GALP directly into the brain leads to a reduction in the secretion of thyroid-stimulating hormone (TSH), which indicates the involvement of GALP in the neuroendocrine regulation of the hypothalamic-pituitary-thyroid (HPT) axis, and further adding to the evidence of the role of GALP in energy homeostasis.
Throughout the 15th and 16th centuries, Portuguese explorers sailed the coast of Africa, established trading posts [[Economic history of Portugal#Expansion of the Portuguese empire (15th and 16th centuries)|for commodities]] especially gold and slaves, explored the Indian Ocean and eastern Asia, and established trade routes in most of southern Asia, taxing most trade criss-crossing the Indian Ocean. However, by the 16th century its enterprise in Asia was already in decline. The 1494 Treaty of Tordesillas divided newly encountered non-European territories between Portugal and Spain along a meridian west of Cape Verde, while the 1529 Treaty of Zaragoza extended this partition to the Pacific Ocean. In 1498, Vasco da Gama reached India by sea, and two years later Pedro Álvares Cabral landed in Brazil and claimed it for Portugal. During the 15th century, Portugal established the transatlantic slave-trade circuits and, by the mid-19th century, had become one of the longest-active and a significant participant in the Atlantic slave trade.
Fourteen distinct types are available in addition to botanical tulips, including Lily-flowered, Fringed, Viridiflora, and Rembrandt. In addition to blooming season, tulip varieties differ in shape and height, and exhibit a wide range of colours, both pure and in combination.
Sources: en.wikipedia.org
Method validation is the documented process of confirming that an HPLC procedure is suitable for its intended use. It evaluates accuracy, precision, specificity, linearity, range, detection limits, and robustness. Validation criteria depend on the regulatory context and the sample type.
System suitability tests are short checks performed before or during an HPLC run to verify instrument and method performance. They often include resolution, tailing factor, theoretical plates, and injection precision. Results must meet predefined limits for sample data to be accepted.
HPLC retention time alone cannot definitively identify an unknown substance. A match with a reference standard under identical conditions provides supporting evidence. Confirmation typically requires mass spectrometry, nuclear magnetic resonance, or another orthogonal technique.
Method validation is the documented process of showing that an HPLC procedure produces reliable results for a defined purpose. It examines parameters such as accuracy, precision, specificity, linearity, and robustness. Regulators and quality systems often require validation before routine use.